Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer Therapy
Juhua Zhou(Zhejiang Chinese Medical University), Paul F. Robbins(National Cancer Institute)
Cited by 330
Related Papers
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
|The Journal of Experimental Medicine|1996|547
High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines
|The Journal of Immunology|2007|216
TIL therapy broadens the tumor-reactive CD8<sup>+</sup>T cell compartment in melanoma patients
|OncoImmunology|2012|176